Adamis Pharmaceuticals | L'Utile Ante Imposte



L'Utile Ante Imposte Cambiamento Data
Adma Biologics USD 47.52M 7.42M 2025-09
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Brainstorm Cell Therapeutics USD -2.86M 109K 2025-03
Cara Therapeutics USD -4.91M 3.17M 2025-03
Cipla INR 11.69B 6.85B 2025-12
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD -6.94M 421K 2025-09
CSL USD 1.4B 1.14B 2025-06
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Glaxosmithkline GBP 2.46B 569M 2025-09
Grifols EUR 66.98M 19.92M 2024-06
Merck USD 6.74B 22M 2025-09
Pfizer USD 3.33B 290M 2025-09
RedHill Biopharma USD -1.54M 12M 2024-06


Adamis Pharmaceuticals L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.